Subscribe To
NRXP / NRx Pharmaceuticals, Inc. (NRXP) Q3 2022 Earnings Call Transcript
NRXP News
By PRNewsWire
October 5, 2023
NRx Pharmaceuticals to Present at 8th Annual Dawson James Conference
RADNOR, Pa. , Oct. 5, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharma more_horizontal
By Zacks Investment Research
October 3, 2023
NRx Pharma (NRXP) to Initiate Clinical Study on NRX-101, Stock Up
NRx Pharma (NRXP) receives FDA clearance to begin clinical development for its lead candidate, NRX-101, to treat chronic pain. more_horizontal
By PRNewsWire
September 18, 2023
NRx Pharmaceuticals to Present at the Sidoti Virtual Small Cap Conference
RADNOR, Pa. , Sept. 18, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biophar more_horizontal
By PRNewsWire
September 7, 2023
NRx Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
RADNOR, Pa. , Sept. 7, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biophar more_horizontal
By Seeking Alpha
August 14, 2023
NRX Pharmaceuticals, Inc. (NRXP) Q2 2023 Earnings Call Transcript
NRX Pharmaceuticals, Inc. (NASDAQ:NRXP ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Matthew Duffy - Chief Busine more_horizontal
By PRNewsWire
August 7, 2023
NRx Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 14, 2023
RADNOR, Pa. , Aug. 7, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a late-stage biopharmaceu more_horizontal
By PRNewsWire
June 2, 2023
NRx Pharmaceuticals to Host Corporate and Strategic Update Conference Call on Monday, June 5, 2023
RADNOR, Pa. , June 2, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharma more_horizontal
By Zacks Investment Research
May 31, 2023
All You Need to Know About NRx Pharmaceuticals, Inc. (NRXP) Rating Upgrade to Buy
NRx Pharmaceuticals, Inc. (NRXP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank more_horizontal
